Sofinnova raises €165M for new early-stage biotech fundnews2025-03-18T08:15:05+00:00March 18th, 2025|Endpoints News|
GRO Biosciences, working on recoded organisms, cuts most staffnews2025-03-17T12:45:21+00:00March 17th, 2025|Endpoints News|
Curevo gets $110M for a shot against Shingrix, gets Moncef Slaoui and Tal Zaks on boardnews2025-03-17T12:00:41+00:00March 17th, 2025|Endpoints News|
Otsuka’s Taiho buys Swiss startup Araris with three ADCs nearing the clinicnews2025-03-17T11:30:33+00:00March 17th, 2025|Endpoints News|
HC Bioscience, a tRNA biotech backed by ARCH and Takeda, shuts downnews2025-03-17T11:06:04+00:00March 17th, 2025|Endpoints News|
Latigo collects $150M to get non-opioid data to compete with Vertex in acute painnews2025-03-17T09:00:49+00:00March 17th, 2025|Endpoints News|
Eli Lilly-backed Maxion Therapeutics raises $72M Series A to advance its antibody approachnews2025-03-17T07:00:48+00:00March 17th, 2025|Endpoints News|
Lilly-partnered Fauna Bio plans $40M Series A to get into heart failurenews2025-03-14T09:39:55+00:00March 14th, 2025|Endpoints News|
Montara Therapeutics adds $20M to seed fundraise for neurology pipelinenews2025-03-13T12:00:29+00:00March 13th, 2025|Endpoints News|
Insilico nabs $110M Series E for AI drug discovery after stalling Hong Kong IPO plansnews2025-03-12T13:48:40+00:00March 12th, 2025|Endpoints News|
